194 results on '"Sparling, David"'
Search Results
2. Real-Time Continuous Glucose Monitoring Reduced Costly Diabetes-Related Events in Adolescents and Young Adults despite Lack of Short-Term Reduction in Hemoglobin A1c
3. Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity
4. Greening Manufacturing Supply Chains – Introducing Bio-based Products into Manufacturing Supply Chains
5. Regulation and the financial performance of Canadian agribusinesses
6. Australian Biotechnology IPOs: Too Early, Too Small?
7. Simulations and supply chains: strategies for teaching supply chain management
8. Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry
9. Hyperphosphorylation of MEF2A in primary adipocytes correlates with downregulation of human GLUT4 gene promoter activity
10. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase
11. A Framework for Translating Biotechnology Experiences to Nanotechnology
12. 111-OR: MODY3 Diagnosis from Deidentified Pancreatic Tissue Leads to Variant Identification in Living Relatives
13. Inhibition of γ-secretase in adipocytes leads to altered IL-6 secretion and adipose inflammation
14. Novel role for an HPt domain in stabilizing the phosphorylated state of a response regulator domain
15. Weight Loss Results in Increased Expression of Anti‐Inflammatory Protein CRISPLD2 in Mouse Adipose Tissue
16. Firm, market, and regulatory factors influencing innovation and commercialization in Canada's functional food and nutraceutical sector
17. Strategic Alliances in the Canadian Biotechnology Sector
18. Further thoughts on the relationship between economic valued added and stock market performance
19. An assessment of the strategies and strengths of medium-sized food processors
20. Macrophage‐Derived microRNA‐155 Increases in Obesity and Influences Adipocyte Metabolism by Targeting Peroxisome Proliferator‐Activated Receptor Gamma
21. 1277-P: Diabetes Management Supplies in Youth with Type 1 Diabetes: Don’t Leave Home Without Them!
22. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study
23. Managing and reducing total cycle time: models and analysis
24. TML Foods Inc.
25. Murgo Farms Inc.: HACCP, ISO 9000, and ISO 14000
26. Essex Continental Distributors Inc.
27. Adipocyte Gamma-Secretase Inhibition May Alter IL-6 Expression and Trafficking
28. Factors affecting biotechnology innovation in Canada: analysis of the 2001 biotechnology use and development survey
29. Substitutes versus Complements among Canadian Business Risk Management Programs
30. mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2
31. Congenital hypothyroidism and thyroid dyshormonogenesis: a case report of siblings with a newly identified mutation in thyroperoxidase
32. Development of sustainable microbial fermentation strategies for the production of medium-chain length polyhydroxyalkanoates (mcl-PHAs) from biodiesel derived glycerol
33. Farm Support Payments and Risk Balancing: Implications for Financial Riskiness of Canadian Farms
34. A Comment on "Peer Review in Ambulatory Care"
35. Canada’s shrinking Bioproduct Industry
36. Identifying successful business models, strategies and policies for promoting the Canadian Bioeconomy
37. Competitiveness of Canadian Agri-Food Supply Chains - Policy Brief
38. Innovation and Competitiveness - A Policy Brief
39. Policy, Industry Strategy and Healthy Food Innovation
40. Innovation and Bioproduct Development
41. North American Retailers and Their Impact on Food Chains
42. Bioproducts Development Survey: Analysis of the Summary Results
43. The Canadian Bioproducts Industry Analysis of the Bioproduct Development Survey - 2004
44. An Analysis of Financing Innovation and Commercialization in Canada's Functional Food and Nutraceutical Sector
45. Costs and Benefits of Traceability in the Canadian Dairy-Processing Industry
46. Traceability in the Canadian Dairy Processing Sector
47. HARMONIZING INTERNATIONAL AGREEMENTS WITH RESPECT TO INTEGRATED AGRICULTURAL MARKETS: BSE CASE STUDY (PowerPoint Presentation)
48. Factors Affecting Biotechnology Innovation in Canada: Analysis of the 2001 Biotechnology Use and Development Survey
49. Risk Management in the Integrated NAFTA Market: Lessons from the Case of BSE
50. Farm Support Payments and Risk Balancing: Implications for Financial Riskiness of Canadian Farms
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.